|
US1786412A
(en)
*
|
1929-11-20 |
1930-12-23 |
American Telephone & Telegraph |
Shielding arrangement
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
EP0487587A1
(en)
|
1989-08-18 |
1992-06-03 |
Chiron Corporation |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
|
WO1991012325A1
(en)
|
1990-02-09 |
1991-08-22 |
E.I. Du Pont De Nemours And Company |
Htlv envelope antigenic segment
|
|
US5466468A
(en)
|
1990-04-03 |
1995-11-14 |
Ciba-Geigy Corporation |
Parenterally administrable liposome formulation comprising synthetic lipids
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US6113914A
(en)
|
1991-08-15 |
2000-09-05 |
Smithkline Beecham Biologicals (S.A.) |
Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
|
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
|
ES2105262T3
(es)
|
1992-05-18 |
1997-10-16 |
Minnesota Mining & Mfg |
Dispositivo de suministro de farmaco a traves de las mucosas.
|
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
|
JPH08505625A
(ja)
|
1993-01-11 |
1996-06-18 |
ダナ−ファーバー キャンサー インスティチュート |
細胞毒性ｔリンパ球応答の誘導
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5551622A
(en)
|
1994-07-13 |
1996-09-03 |
Yoon; Inbae |
Surgical stapler
|
|
AT402926B
(de)
|
1994-12-05 |
1997-09-25 |
Hafslund Nycomed Pharma |
Heterocyclische amide, verfahren zu ihrer herstellung und verwendung
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5580579A
(en)
|
1995-02-15 |
1996-12-03 |
Nano Systems L.L.C. |
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
CA2220530A1
(en)
|
1995-06-02 |
1996-12-05 |
Incyte Pharmaceuticals, Inc. |
Improved method for obtaining full-length cdna sequences
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
CN1154730C
(zh)
|
1995-09-01 |
2004-06-23 |
科里克萨有限公司 |
用于结核病诊断的化合物和方法
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
CZ300688B6
(cs)
|
1995-09-01 |
2009-07-15 |
Corixa Corporation |
Polypeptid, farmaceutický prostredek a vakcína s jeho obsahem, zpusob prípravy a použití polypeptidu, molekula rekombinantní DNA a její použití, expresní vektor, hostitelská bunka, fúsní porotein a diagnostický kit
|
|
US6290969B1
(en)
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6338852B1
(en)
|
1995-09-01 |
2002-01-15 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6592877B1
(en)
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
EP0871747A1
(en)
|
1996-01-02 |
1998-10-21 |
Chiron Viagene, Inc. |
Immunostimulation mediated by gene-modified dendritic cells
|
|
WO1998016645A2
(en)
|
1996-10-11 |
1998-04-23 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6627198B2
(en)
|
1997-03-13 |
2003-09-30 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis antigens and their uses
|
|
US6544522B1
(en)
|
1998-12-30 |
2003-04-08 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
US6350456B1
(en)
|
1997-03-13 |
2002-02-26 |
Corixa Corporation |
Compositions and methods for the prevention and treatment of M. tuberculosis infection
|
|
US6555653B2
(en)
|
1997-05-20 |
2003-04-29 |
Corixa Corporation |
Compounds for diagnosis of tuberculosis and methods for their use
|
|
US6613881B1
(en)
|
1997-05-20 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
|
|
ATE513042T1
(de)
|
1998-02-05 |
2011-07-15 |
Glaxosmithkline Biolog Sa |
Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen, die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
|
|
KR100797876B1
(ko)
*
|
1998-04-07 |
2008-01-24 |
코릭사 코포레이션 |
마이코박테리움 튜베르쿨로시스 항원의 융합 단백질 및이의 용도
|
|
AU750587B2
(en)
|
1998-10-16 |
2002-07-25 |
Smithkline Beecham Biologicals (Sa) |
Adjuvant systems and vaccines
|
|
AU779978B2
(en)
|
1999-10-07 |
2005-02-24 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
DE60139963D1
(de)
*
|
2000-06-20 |
2009-10-29 |
Corixa Corp |
Fusionsproteine aus mycobakterium tuberculosis
|
|
US20040121322A9
(en)
|
2001-02-22 |
2004-06-24 |
Cole Stewart T. |
Comparative mycobacterial genomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
|
|
WO2002072792A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Corixa Corporation |
Heterologous fusion protein constructs comprising a leishmania antigen
|
|
ATE434637T1
(de)
|
2002-02-14 |
2009-07-15 |
Mitsui Chemicals Inc |
Polyesterharz und katalysator für die polyesterherstellung, verfahren zur herstellung von polyesterharz mit dem katalysator.
|
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
|
DK1511768T3
(da)
*
|
2002-06-11 |
2007-08-20 |
Glaxosmithkline Biolog Sa |
Immunogene sammensætninger
|
|
US7205259B2
(en)
|
2002-07-26 |
2007-04-17 |
Kimberly-Clark Worldwide, Inc. |
Absorbent binder desiccant composition and articles incorporating it
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
US7301098B2
(en)
|
2005-01-19 |
2007-11-27 |
Panduit Corp. |
Communication channels with suppression cores
|
|
SI2457926T1
(sl)
|
2005-04-29 |
2015-01-30 |
Glaxosmithkline Biologicals S.A. |
Nov postopek za preprečevanje ali zdravljenje infekcije z M. tuberculosis
|
|
US8475803B2
(en)
*
|
2005-04-29 |
2013-07-02 |
Fusion Antibodies Limited |
Assays for diagnosis of tuberculosis and uses thereof
|
|
PT1880008E
(pt)
|
2005-05-03 |
2015-08-27 |
Inserm Inst Nat De La Santé Et De La Rech Médicale |
Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada
|
|
JP4468858B2
(ja)
|
2005-06-01 |
2010-05-26 |
オリンパスイメージング株式会社 |
データ符号化装置、データ符号化方法、プログラム
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US7296798B2
(en)
|
2006-01-31 |
2007-11-20 |
Matt Overfield |
Gameboard, games played on board and methods of play requiring strategy and luck
|
|
WO2008007942A1
(en)
*
|
2006-07-10 |
2008-01-17 |
Het Nederlands Kanker Instituut |
Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof
|
|
ES2397714T3
(es)
|
2006-10-12 |
2013-03-08 |
Glaxosmithkline Biologicals S.A. |
Vacuna que comprende un adyuvante de emulsión de aceite en agua
|
|
EP2087128A4
(en)
*
|
2006-11-01 |
2009-11-04 |
Immport Therapeutics Inc |
COMPOSITIONS AND METHODS FOR IMMUNOMINANT ANTIGENES
|
|
GB0622282D0
(en)
*
|
2006-11-08 |
2006-12-20 |
Novartis Ag |
Quality control methods
|
|
CA2679410C
(en)
*
|
2007-03-02 |
2017-01-17 |
Glaxosmithkline Biologicals S.A. |
Novel method and compositions
|
|
GB0716070D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Fusion Antibodies Ltd |
Diagnostic method and kit
|
|
US7670609B2
(en)
*
|
2007-11-27 |
2010-03-02 |
Aeras Global Tb Vaccine Foundation |
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
|
|
FR2933552B1
(fr)
|
2008-07-04 |
2014-10-10 |
Centre Nat Rech Scient |
Circuit d'amplification d'un signal representant une variation de resistance d'une resistance variable et capteur correspondant
|
|
AU2009273130B2
(en)
*
|
2008-07-25 |
2014-10-16 |
Glaxo Group Limited |
Novel compositions and methods
|
|
KR20170072366A
(ko)
|
2009-04-24 |
2017-06-26 |
스태튼스 세룸 인스티튜트 |
재활성화를 예방하기 위한 결핵 백신
|
|
CN104534426B
(zh)
|
2009-07-21 |
2018-11-09 |
库柏技术公司 |
将发光二极管模块连接于散热器组件、反光件以及电路
|
|
UA110103C2
(uk)
*
|
2010-01-27 |
2015-11-25 |
Ґлаксосмітклайн Байолоджікалз С.А. |
Модифікований туберкульозний антиген
|
|
US9119754B2
(en)
|
2011-10-08 |
2015-09-01 |
Michael Dennis |
Mattress overlay system with positionally adjustable, lateral ramp-wedge bolster structure
|
|
US9051890B2
(en)
|
2013-10-28 |
2015-06-09 |
Ford Global Technologies, Llc |
Method for estimating charge air cooler condensation storage with an intake oxygen sensor
|
|
US9903268B2
(en)
|
2015-04-02 |
2018-02-27 |
Ford Global Technologies, Llc |
Internal combustion engine with two-stage supercharging capability and with exhaust-gas aftertreatment arrangement, and method for operating an internal combustion engine
|
|
US9810514B2
(en)
|
2015-09-08 |
2017-11-07 |
Deufol Sunman Inc. |
Ammunition carrier consumer package
|